ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,478.34
      -0.36%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. CG Oncology Inc (CGON)

      7. CG Oncology Inc (CGON) News

      CGON

      CG Oncology (CGON)

      CG Oncology Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CGON
      DateTimeSourceHeadlineSymbolCompany
      05/24/20248:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGONCG Oncology Inc
      05/24/20248:00AMGlobeNewswire Inc.CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC at ASCO 2024 Annual MeetingNASDAQ:CGONCG Oncology Inc
      05/09/20248:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGONCG Oncology Inc
      05/09/20248:00AMGlobeNewswire Inc.CG Oncology Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:CGONCG Oncology Inc
      05/09/20246:07AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CGONCG Oncology Inc
      05/03/202411:23AMGlobeNewswire Inc.Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder CancerNASDAQ:CGONCG Oncology Inc
      04/26/20248:00AMGlobeNewswire Inc.CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024NASDAQ:CGONCG Oncology Inc
      04/24/202410:00AMGlobeNewswire Inc.CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024NASDAQ:CGONCG Oncology Inc
      03/28/20248:00AMGlobeNewswire Inc.CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual MeetingNASDAQ:CGONCG Oncology Inc
      02/27/20248:00AMGlobeNewswire Inc.CG Oncology Announces First Patient Dosed in PIVOT-006 Phase 3 Clinical Trial of Cretostimogene in Intermediate-risk Non-Muscle Invasive Bladder CancerNASDAQ:CGONCG Oncology Inc
      01/30/20247:00AMBusiness WireCG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:CGONCG Oncology Inc
       Showing the most relevant articles for your search:NASDAQ:CGON

      Your Recent History

      USOTC
      KKPT
      KoKo Petroleum (CE)
      LSE
      AHI
      Allied Healthcare
      Delayed Upgrade Clock